An kafa shi a cikin 2009, JYMed shine babban mai ba da sabis na peptide CRDMO kuma mai ƙera API mai ƙira a cikin Sin ƙwararre a cikin ƙirar al'ada, haɓaka tsari, wadatar asibiti da kasuwanci na abubuwan peptide. Kamfanin yana ɗaukar kusan 600+ FTEs, tare da ƙungiyar gudanarwa ta asali wacce ta ƙunshi ƙwararru waɗanda sama da shekaru 20 na gogewa a fasahar peptide. JYMed yana aiki da cibiyar R&D guda ɗaya da manyan wuraren samarwa da yawa da yawa, tare da ƙarfin masana'antar peptide mai yawan ton.
JYMED
samfurori
HIDIMAR CRO
HIDIMAR CRO
A matsayin kamfanin mai da hankali kan abokin ciniki, JYMed yana ba da cikakkiyar haɓaka peptide da dandamali na masana'antu wanda ke goyan bayan shekaru 20 na ƙwarewar R&D da kayan aikin zamani. Muna isar da peptides masu inganci waɗanda suka dace da bukatun kowane abokin ciniki.
APIs na Peptide
APIs na Peptide
JYMed yana ba da babban fayil na sama da 20 peptide APIs, gami da Semaglutide, Tirzepatide, Liraglutide, Degarelix, da Oxytocin. Yawancin waɗannan, irin su Semaglutide da Tirzepatide, sun sami nasarar kammala rajista da kasuwanci.
HIDIMAR CDMO
HIDIMAR CDMO
JYMed yana ba da cikakkiyar dandamali na CDMO mai inganci, yana ba da cikakken sabis na bakan don samfuran peptide da peptide-analog. Wannan ya haɗa da bincike da samar da peptides na warkewa, peptides na dabbobi, da ƙari.
Peptide na kwaskwarima
Peptide na kwaskwarima
JYMed yana samar da peptides na kwaskwarima masu inganci, albarkatun ƙasa, da samfuran OEM waɗanda suka kama daga bincike zuwa darajar cGMP-duk suna ƙarƙashin kulawar inganci. peptides ɗinmu na roba suna da kima sosai don amincin su, tsabta, da sauƙin gyare-gyare.
GAME DA
JYMED
JYMed shine masana'antar peptide na Amurka da aka bincikar FDA wanda ya kware a peptides na kwaskwarima, peptide APIs, da peptides na al'ada. Abubuwan da muka fito sun haɗa da Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, da ƙari. Don ƙarin koyo, da fatan za a tuntuɓe mu a:
Email: jymed@jymedtech.com
-
Tabbacin inganci
Tabbacin inganci
Duba cikakkun bayanai -
Taimakon Al'amuran Mulki
Taimakon Al'amuran Mulki
Duba cikakkun bayanai -
Fa'idodi a cikin R&D da Kasuwanci
Fa'idodi a cikin R&D da Kasuwanci
Duba cikakkun bayanai -
Halayen haƙƙin mallaka
Halayen haƙƙin mallaka
Duba cikakkun bayanai -
Takaddun cancanta
Takaddun cancanta
Duba cikakkun bayanai
labarai da bayanai
Shiga JYMed a CPHI Kudu maso Gabashin Asiya 2025
Muna farin cikin shiga cikin shugabannin masana'antu a CPHI Kudu maso Gabashin Asiya 2025, wanda ke faruwa daga Yuli 16 zuwa 18 a MITEC a Kuala Lumpur. Taron ya zagaya sama da murabba'in murabba'in 15,000 kuma zai ƙunshi masu nunin 400. Fiye da kwararru 8,000 ne ake sa ran za su halarta, tare da tarukan karawa juna sani na 60+ da tarukan f...
CPHI ShangHai 2025
Daga ranar 24 zuwa 26 ga watan Yunin shekarar 2025, an yi nasarar gudanar da bikin baje koli na kasa da kasa karo na 23 na kasar Sin CPhI a babban dakin baje koli na birnin Shanghai! Kungiyar ta tsunduma kai tsaye tare da cikakken l...
Haɗu da JYMed a Makon Interphex Tokyo 2025
Muna farin cikin sanar da cewa JYMed za ta baje kolin a makon Interphex Tokyo daga Yuli 9 zuwa 11, 2025, a Tokyo Big Sight (Ariake). Wannan babban taron ya haɗa kan masu baje kolin 90 da kusan ƙwararrun 34,000 daga ko'ina cikin masana'antar harhada magunguna da kayan shafawa. Kamar yadda daya daga cikin Asiya ...
